Conexeu Sciences Inc.
Conexeu Sciences Inc. is pioneering a new class of wound care and aesthetic products based on innovative tissue research in regenerative medicine. The company leads the development and commercialization of cellular therapies for skin restoration, targeting applications such as burns, acute wounds, diabetic ulcers, and aesthetic soft tissue fillers.
Industries
Nr. of Employees
small (1-50)
Conexeu Sciences Inc.
Patents
Products
ECM-derived in situ gelling skin substitute (liquid cell therapy scaffold)
A liquid extracellular-matrix-derived therapeutic scaffold that is liquid at room temperature and self-gels in situ in approximately 10 minutes at ~34°C; designed to mimic tissue, integrate with host cells, promote epithelial advancement, reduce inflammation and minimize fibrotic scarring. Reported use cases include wound repair support for flaps, mesh grafts, burns, acute wounds and diabetic ulcers, and aesthetic soft-tissue filler applications.
ECM-derived in situ gelling skin substitute (liquid cell therapy scaffold)
A liquid extracellular-matrix-derived therapeutic scaffold that is liquid at room temperature and self-gels in situ in approximately 10 minutes at ~34°C; designed to mimic tissue, integrate with host cells, promote epithelial advancement, reduce inflammation and minimize fibrotic scarring. Reported use cases include wound repair support for flaps, mesh grafts, burns, acute wounds and diabetic ulcers, and aesthetic soft-tissue filler applications.
Services
End-to-end development activities for cell-based skin restoration products, including preclinical and early clinical validation and commercialization planning.
Partnerships to move university-developed scaffold technology into applied product development and early clinical evaluation.
End-to-end development activities for cell-based skin restoration products, including preclinical and early clinical validation and commercialization planning.
Partnerships to move university-developed scaffold technology into applied product development and early clinical evaluation.
Expertise Areas
- Regenerative medicine
- Wound care product development
- Cellular therapy development
- Tissue engineering
Key Technologies
- Extracellular matrix (ECM)-derived scaffolds
- In situ gelling biomaterials
- Cell-based therapeutic products
- Tissue integration engineering